Inhibrx Biosciences, Inc.

INBX

NASDAQ

Healthcare

Biotechnology

La Jolla, CA, US156 employeesinhibrx.com

$63.59

-3.46(-5.17%)

Mkt Cap $929M

$10.84

$93.51

52-Week Range

At a Glance

AI-generated

Inhibrx Biosciences, Inc.

Revenue breakdown: License Non Affiliate (66.7%), License (33.3%).

8-K

Inhibrx Biosciences, Inc. reported financial results for Q4 and fiscal year 2025, with net loss of $32.8 million ($2.11 per share) for Q4 and $140.1 million ($9.04 per share) for the year, compared to prior year net loss and net income respectively. Cash and cash equivalents stood at $124.2 million as of December 31, 2025, with $75.0 million gross proceeds from loan amendment on March 18, 2026.

$929M

Market Cap

$1M

Revenue

-$132M

Net Income

Employees156

Fundamentals

How The Business Makes Money

Revenue by Segment

License Non Affiliate66.7%($3M)

License33.3%($2M)

Activity

What Changed Recently

Financial Results

Mar 18, 2026

of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section

Regulation FD

Feb 22, 2026

of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section

Peer Companies

Company	Price	Change	Market Cap	P/E
ELVNEnliven Therapeutics, Inc...	$38.72	+2.45%	$2.3B	-16.8
RLAYRelay Therapeutics, Inc.	$12.56	+16.67%	$2.2B	-6.1
SNDXSyndax Pharmaceuticals, I...	$25.08	+5.04%	$2.2B	-7.3
NKTRNektar Therapeutics	$77.01	+1.72%	$1.6B	-9.2
IMTXImmatics N.V.	$10.36	+3.45%	$1.4B	-5.5
AMLXAmylyx Pharmaceuticals, I...	$15.02	+4.66%	$1.2B	-8.8
CVACCVAC	$4.66	+0.00%	$1.0B	—
ORICORIC Pharmaceuticals, Inc...	$8.90	+19.06%	$893M	-7.5

Analyst View

Company Profile

CIK0002007919

ISINUS45720N1037

CUSIP45720L107

Phone858-795-4220

Address11025 North Torrey Pines Road, La Jolla, CA, 92037, US

SEC EDGAR